Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrite Infusion in High Risk Cardiac Surgery
NCT03331146Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium nitrite in acute kidney injury (AKI) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Nitrite Metabolome Levels, Biomarkers of Hemolysis and 2 more. Planned start Oct 2018; status: withdrawn.
02
Drugs
sodium nitrite
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03331146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331146.